The Junk Safety Science Which Underpins UK Government MMR Vaccine Policy
I recently wrote to Dame Sally Davies, Chief Medical Officer of England and to the British government, asking her for the basis of her statement to the BBC regarding MMR: "It's a safe vaccination - we know that", and was a lucky enough to receive a reply (letter of 12 November, from which I extract):
Specifically in relation to whether MMR vaccines may be a cause of autism, a substantial body of population-based research has found no evidence to suggest a causal association. This evidence (not just for MMR, but other types of vaccine) is available for review in the published medical literature, and was summarised in a meta-analysis in 2014 which is free to download (https://www.sciencedirect.com/science/article/pii/S0264410X14006367?via%3Dihub).
In relation to vaccine safety monitoring more generally, I can assure you that systems are in place to keep safety under review. This includes continual review of suspected adverse reaction reports (such as those submitted through the Yellow Card Scheme), evaluation of GP and hospital-based health records linked to immunisations, review of worldwide data and close collaboration with international health authorities.
It is noteworthy that the "meta-analysis" by Luke E Taylor is identical to the one cited by Thomas Insel to a US Congressional committee in 2014, but it constitutes no more than a bureaucratic fig-leaf. Dame Sally - who is the UK's leading government adviser on medical matters - ought to be able to do a lot better than this if every child is to be subjected to these products. It is, if anything, a rather naive response citing a shallow collection of studies which were published under political pressure decades after the policy was introduced. I have since attempted a conscientious and detailed reply:
21 November 2018
Dear Dame Sally,
Thank you for your letter of 12 November. I would point out that though you are quite right I am concerned about the rise in autism I specifically asked about the evidence base for MMR safety. That said it is reasonable to point out autism for a whole host of reasons is a much more serious problem in modern Britain (and elsewhere) than measles. When the DHSC last surveyed this problem in 2004-5 the overall ASD rate among school children was ~1% which was 5 times higher than the rate for those young people born between 1984-8 mostly before MMR was introduced, as reported in the equivalent 1999 survey. Since then your department has neglected to look at the issue (apart from a couple of failed adult autism surveys) as everything manifestly got worse, year on year [1,2].
As it is, a recent survey carried out by the Department of Health in Northern Ireland showed that the rate had risen from 1.2% in 2009 to 2.9%, while in Belfast it was as high as 4.7%. Moreover, 60% are educational Stage 5 [3], ie the most severe level of disability, so these are not cases that could previously have been missed because somehow subliminal. Educational data from across the nation and reports of collapse in educational services in the media testify that Northern Ireland is not an isolated case, but just better documented [4].
Regarding the meta-review by Taylor 'Vaccines are not associated with autism' [5] which you cited I note that there are just six MMR related studies included all of which have major problems. Three of the studies show apparent protective effect of MMR vaccines against autism (Madsen 8% [6], Smeeth 14% or 22% [7] and Mrozek-Budzyn 83%!!! [8]) which suggests bias. Of the Madsen paper Cochrane 2005 warned [9]:
"The follow up of diagnostic records ends one year (31 Dec 1999) after the last day of admission to the cohort. Because of the length of time from birth to diagnosis, it becomes increasingly unlikely that those born later in the cohort could have a diagnosis"
It remains troubling that as with a number of studies from this Danish group the co-ordinator on behalf of US Centers for Diseases Control, Poul Thorsen, is wanted for financial fraud from the CDC, though not extradited to the US now after nearly 8 years [10].
Of the De Stefano paper Cochrane commented [9]:
“The conclusion, however, implied bias in the enrollment of cases which may not be representative of the rest of the autistic population of the city of Atlanta, USA where the study was set.”
And indeed in 2014 the paper was repudiated by one of the leading authors, William Thompson [11]:
“I regret that my coauthors and I omitted statistically significant information in our 2004 article published in the journal Pediatrics. The omitted data suggested that African American males who received the MMR vaccine before age 36 months were at increased risk for autism. Decisions were made regarding which findings to report after the data were collected, and I believe that the final study protocol was not followed.”
The study by Smeeth [7] is compromised by its patchy data source, the General Practice Research Database where the autism rate represented is perhaps only one tenth of cases diagnosed [12]. Cochrane commented [9]:
“In the GPRD - based studies (Black 2003; Smeeth 2004) the precise nature of controlled unexposed to MMR and their generalisability was impossible to determine…”
It remains problematic whether the unvaccinated in this study were genuinely unvaccinated.
Of the Uchiyama study [13] Cochrane commented [14]:
“The cohort study of Uchiyama 2007 was potentially affected by a different type of bias, considering that the participants were from a private clinic and that definitions of applied Autistic Spectrum Disorders (ASD) diagnosis and of methods used for ASD regression ascertainment were not clearly reported.”
And the Uno study [15] will suffer from similar issues since the cases came from the same clinic. Moreover, in both instances the studies were far too small (904 persons and 413) to necessarily provide any clear result even if they had been better controlled.
Nor can the Taylor meta-analysis [5] cover up the entire absence of pre-marketing studies. In 1988-9 when the British government was persuaded to introduce Pluserix, MMR2 and Imravax there were no safety studies at all, and successive governments have been forced into the defence of a policy which they had embarked on without safety evidence.
As to the robustness of the yellow card reporting system I note the recent correspondence in the columns of BMJ On-Line regarding monitoring of Pandemrix vaccine from Wendy E Stephen and Clifford G Miller [16], which has serious implications for how the MHRA monitor all products. The MHRA has, of course, the ultimate conflict of being entirely funded by the manufacturers. It may be mentioned that in 1992 the Pluserix and Imravax vaccines were withdrawn not apparently by the British Government concerned about patient safety but by the manufacturers catching the government on the hop [17].
We are confronting a catastrophic situation among our young people with chronic illness replacing infectious illness as the main issue and cost to the state, and laying the emphasis on infectious diseases (with endless hate campaigns in the media against critics labelled “anti-vaxxers”) is a distraction, and a distortion of policy. It would be unfortunate if ministers were being advised about the safety of the programme on such a threadbare and inadequate basis. Re-examining the policy is both essential and urgent.
[1] John Stone, ‘Response to David Oliver I (The Indisputable Rise in Autism)’, BMJ Rapid Responses 28 August 2018, https://www.bmj.com/content/362/bmj.k3596/rr-12
[2] John Stone, ‘What about autism?’ BMJ Rapid Responses, 21 August 2018, https://www.bmj.com/content/362/bmj.k3596/rr-0
[3] Information Analysis Directorate 'The Prevalence of Autism (including Asperger Syndrome) in School Age Children in Northern Ireland 2018', published 10 May 2018, https://www.health-ni.gov.uk/sites/default/files/publications/health/asd-children-ni-2018.pdf
[4] Responses to Viner RM, 'NHS must prioritise health of children and young people', https://www.bmj.com/content/360/bmj.k1116/rapid-responses
[5] Luke E Taylor et al, ‘Vaccines are not associated with autism: An evidence-based meta-analysis of case-control and cohort studies’, Vaccine 2014, https://autismoevaccini.files.wordpress.com/2014/05/vaccines-are-not-associated-with-autism.pdf
[6] Madsen et al, ‘A Population-Based Study of Measles, Mumps, and Rubella Vaccination and Autism’, NEMJ 2002, https://www.nejm.org/doi/full/10.1056/NEJMoa021134
[7] Smeeth et al, ‘MMR vaccination and pervasive developmental disorders: a case-control study.’ Lance 2004, https://www.ncbi.nlm.nih.gov/pubmed/15364187
[8] Mrozek-Budzyn et al, ‘Lack of association between measles-mumps-rubella vaccination and autism in children: a case-control study.’ Pediatric Infectious Diseases Journal 2010, https://www.ncbi.nlm.nih.gov/pubmed/19952979
[9] Demicheli et al, ‘Vaccines for measles, mumps and rubella in children.’, Cochrane Database Syst Rev. 2005 Oct 19;(4):CD004407.
[10] Office of Inspector General, US Department of Health and Human Services, Fugitive Profiles, https://oig.hhs.gov/fraud/fugitives/profiles.asp
[12] John Stone, ‘An old story: the GPRD does not provide credible autism data’ 11 February 2014 https://bmjopen.bmj.com/content/3/10/e003219.responses
[13] Uchiyama et al, ‘MMR-vaccine and regression in autism spectrum disorders: negative results presented from Japan.’ J Autism Dev Disord. 2007 Feb;37(2):210-7.
[14] Demicheli et al, ‘Vaccines for measles, mumps and rubella in children.’, Cochrane Systematic Review - Intervention Version published: 15 February 2012, https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004407.pub3/full
[15] Uno et al, ‘The combined measles, mumps, and rubella vaccines and the total number of vaccines are not associated with development of autism spectrum disorder: the first case-control study in Asia’, Vaccine. 2012 Jun 13;30(28):4292-8. doi: 10.1016/j.vaccine.2012.01.093. Epub 2012 Apr 20.
[16] Responses to Godlee, ‘A tale of two vaccines’ BMJ 2018, https://www.bmj.com/content/363/bmj.k4152/rapid-responses
[17] Report, BMJ 26 September 1992, https://www.bmj.com/content/305/6856/777
When your government, the BBC or the mainstream media tell you that MMR is safe, this the best that the British government can do. After three decades of pure bluster they need to go back to the drawing board.
Patricia
Yes, I distinctly recall Dame Sally’s predecessor Sir Liam Donaldson calling the Wakefield paper “junk science” in 2004 - the reality is these people had zero science - contrasted with willingness of Wakefield and colleagues to look meticulously at individual cases (the very last thing they wanted). And the parade of stupidity goes on all these years later as we reach the end of 2018 - more and more bluster, less and less science.
Your point about the autism label is well taken, but I fear it is too late to do anything.
Posted by: John Stone | November 29, 2018 at 09:09 AM
John just a PS to say that you could not have bettered your brilliant robust reply to Dame Sally. A more precise nailing of facts to your mast must have disturbed her complacancy! Her blank refusal to respond in kind confirms all we are only too familiar with. Hey ho....onwards and upwards John.
Posted by: Patricia | November 29, 2018 at 08:19 AM
John before i go back and properly read these dense letters i do wish we could start to substitute the words ‘special needs’ for that inflammatory word ‘autistic’. These children are now beginning to overwhelm our schools both here in uk and the US - so much so that whole ‘special needs schools’ are now on the drawing boards. But i have yet to hear from either medical or educational authorities any explanation for this extraordinary phenomena! Have you heard any? I wonder what Dame Sally has to say about it!
Posted by: Patricia | November 28, 2018 at 04:50 AM
Thank you very much for that article, John. If prescription drugs can not be trusted like Valsartan that I was taking for several years for high blood pressure and has now been discovered to cause various kinds of cancer, then why would vaccines be trusted either?
Especially when children/adults with autism have immune panels that show they have elevated measles titers not found in normal children/adults after receiving the MMR vaccine.
Why is that? How do the doubters explain that "small" fact?
Posted by: Raymond Gallup | November 27, 2018 at 06:59 PM
Of course dont do as I do,do as I say- get your vaccines and stop drinking alcohol...wonder if her, kids are fully vaxxed..
https://www.dailymail.co.uk/news/article-3431444/The-health-hypocrite-Chief-medical-officer-told-women-think-cancer-reaching-wine-pictured-enjoying-drinks-family.html
Britain's top doctor has been terrorising moderate drinkers into giving up wine and lecturing women to consider every sip of alcohol a deadly step towards breast cancer.
But it appears Dame Sally Davies - the UK's 'nanny in chief' who only this week urged others to 'do as I do' - has relaxed her killjoy approach to booze at home.
New photographs show the chief medical officer clutching a half-full champagne flute in the lounge of her £3milllion London townhouse.
Pharma For Prison
MMR RIP
Posted by: Angus Files | November 27, 2018 at 12:03 PM
Here are some sobering statistics that should give pause to anybody considering exposing themselves to unnecessary toxins for little or no benefit. (This is from an upcoming Duty to Warn column entitled: Vaccinology Realities that Neither Doctors nor Their Patients are Taught - And Why America’s Over-vaccination Mandates are Inherently Unsafe and of Questionable Usefulness
Commonly-mandated Childhood Vaccines and the Incidence of the Diseases they are Supposed to Prevent
DTaP: Diphtheria is non-existent in the US population
DTaP: Tetanus is rare in the US population
DTaP
Pertussis (Bordetella pertussis - aka “whooping cough”) has an incidence of 55.2 cases per 100,000 infants less than 12 months of age; (98.2 cases per 100,000 6 month-old infants or younger).
The incidence of pertussis has actually been gradually increasing since the early 1980s. A total of 25,827 cases was reported in 2004, the largest number since 1959. The reasons for the increase are not clear. A total of 27,550 pertussis cases and 27 pertussis-related deaths were reported in 2010. Case counts for 2012 have surpassed 2010, with 48,277 pertussis cases, with 13 deaths in infants (provisional).
During 2001–2003, the highest average annual pertussis incidence was among infants younger than 1 year of age (55.2 cases per 100,000 population), and particularly among children younger than 6 months of age (98.2 per 100,000 population). In 2002, 24% of all reported cases were in this age group. However, in recent years, adolescents (11–18 years of age) and adults (19 years and older) have accounted for an increasing proportion of cases. During 2001–2003, the annual incidence of pertussis among persons aged 10–19 years increased from 5.5 per 100,000 in 2001, to 6.7 per 100,000 in 2002, and 10.9 per 100,000 in 2003.
Hepatitis B
Hepatitis B vaccine is a synthetic, non-infectious vaccine. The incidence of Hepatitis B is 2.1 cases per 100,000 population. The vaccine used to contain thimerosal (mercury) as a preservative and now contains aluminum as an adjuvant.
Based on data from CDC, the incidence of acute hepatitis B in the United States has declined steadily since the late 1980s. Between 1987 and 2004, the incidence of acute hepatitis B was recently reported by the CDC to be 2.1 per 100,000 (6,212 cases reported).
Pneumovax
As few as 2 cases of invasive pneumococcal pneumonia occur annually per 100,000 population. It contains an aluminum adjuvant.
CDC reported dramatic declines in invasive pneumococcal disease among children less than 5 years old. Overall, invasive pneumococcal disease decreased from 100 cases per 100,000 people in 1998 to 9 cases per 100,000 in 2015. Invasive pneumococcal disease caused by the 13 serotypes covered by PCV13 decreased from 91 cases per 100,000 people in 1998 to 2 cases per 100,000 people in 2015.
Hemophilus influenza b (Hib) vaccine
The incidence of Hib infection is as low as 0.08 cases per 100,000 in children younger than 5 years of age.
In the United States, Hib disease is uncommon. In 2015, the incidence of invasive Hib disease was 0.08 cases per 100,000 in children younger than 5 years of age. It occurs primarily in under-immunized children and in infants too young to have completed the primary immunization series.
In 2015, the incidence of non-b H. influenzae invasive disease was 1.3 per 100,000 in children younger than 5 years of age.
Non-typeable H. influenzae, for which there is no vaccine, now causes the majority of invasive H. influenzae disease in all age groups. In 2015, the incidence of invasive non-typeable H. influenzae disease was 7 cases per 100,000 in children younger than 5 years of age and 2 cases per 100,000 in adults 65 years of age and older.
MMR (Measles)
The MMR vaccine contains live (although allegedly attenuated) viruses and therefore contains no mercury. In the US, the incidence of measles is approximately 2 cases per million population.
The incidence of measles has remained below one case per million since 1997, except in 2014, when 667 measles cases were reported, representing a reported incidence of 2.08 cases per million.
MMR (Mumps)
In the US, the incidence of mumps is less than 2 cases per 100,000 population.
In the United States, approximately 3,000 cases of mumps were reported annually in 1983–1985 (= 1.3–1.55 cases per 100,000 population).
MMR (Rubella)
In the US, the incidence of rubella (German measles) is less than 0.5 cases per 100,000 population.
The largest annual number of cases of rubella in the United States was in 1969, when 58 cases were reported per 100,000 population. In 1983, fewer than 1,000 cases per year were reported in the United States (less than 0.5 cases per 100,000 population).
Varicella (Chicken Pox)
The chicken pox vaccine is a live virus vaccine. The incidence of wild-type chicken pox is highly variable and not reportable.
Influenza
Flu viruses have 100 – 200 different strains and therefore influenza has an unpredictable and variable incidence. 80% of what is commonly diagnosed as “vaccine-preventable” influenza is actually “Influenza-Like Illnesses” (ILI) for which there is no vaccine. The commonly over-promoted annual influenza vaccines that come in multiple-dose vials contain the neurotoxic preservative mercury (thimerosal).
Neurotoxic aluminum adjuvants hyper-stimulate immune responses to whatever protein molecules (look up the critically important concept of “Molecular Mimicry”) come to be attached, explaining the large number of vaccine-induced autoimmune (hyperimmune) disorders that are increasingly occurring in fully-vaccinated populations.
Aluminum adjuvants are used in the following vaccines:
DTaP (diphtheria/Tetanus/ Pertussis (whooping cough); Hepatitis A; Hepatitis B; Haemophilus influenza type b; Meningococcus; and Pneumococcal vaccines.
Posted by: Gary G. Kohls MD Kohls | November 27, 2018 at 11:24 AM
Here are some excerpts from a recent Duty to Warn column that will be published soon at any of the following websites: http://duluthreader.com/search?search_term=Duty+to+Warn&p=2; http://www.globalresearch.ca/author/gary-g-kohls; and https://www.transcend.org/tms/search/?q=gary+kohls+articles.
Why most physicians and patients have become so thoroughly convinced that vaccinations are effective is not just the massive propaganda from Big Pharma and Big Medicine that repeatedly supports that notion, but also the relative rarity of the viral illnesses that the vaccines allegedly prevent. See the list below for a multitude of examples regarding that issue.
As just one example of the uselessness of vaccinating all pediatric patients with, for example, a mumps vaccine is the fact that in the United States, only 3,000 cases of mumps were reported annually in 1983–1985, which equates to the exceedingly rare incidence of 1.5 cases per 100,000 population! And yet the CDC and the AAP (American Academy of Pediatrics) mandate several doses of the live mumps virus-containing MMR vaccine for every pre-school child in America. Which means that for every child partially protected from the benign parotid gland infection there will be tens of thousands of children that will be unnecessarily vaccinated, that will receive no benefit, will have to pay the substantial monetary costs and will be unnecessarily exposed to the many toxic ingredients of the vaccine and risk developing a vaccine-induced autoimmune disorder.
<>
Here are some sobering statistics that should give pause to anybody considering exposing themselves to unnecessary toxins for little or no benefit.
_________________________________________________________
Commonly-mandated Childhood Vaccines and the Incidence of the Diseases they are Supposed to Prevent
DTaP: Diphtheria is non-existent in the US population
DTaP: Tetanus is rare in the US population (and also non-contagious)
DTaP
Pertussis (Bordetella pertussis - aka “whooping cough”) has an incidence of 55.2 cases per 100,000 infants less than 12 months of age; (98.2 cases per 100,000 6 month-old infants or younger).
The incidence of pertussis has actually been gradually increasing since the early 1980s. A total of 25,827 cases was reported in 2004, the largest number since 1959. The reasons for the increase are not clear. A total of 27,550 pertussis cases and 27 pertussis-related deaths were reported in 2010. Case counts for 2012 have surpassed 2010, with 48,277 pertussis cases, with 13 deaths in infants (provisional).
During 2001–2003, the highest average annual pertussis incidence was among infants younger than 1 year of age (55.2 cases per 100,000 population), and particularly among children younger than 6 months of age (98.2 per 100,000 population). In 2002, 24% of all reported cases were in this age group. However, in recent years, adolescents (11–18 years of age) and adults (19 years and older) have accounted for an increasing proportion of cases. During 2001–2003, the annual incidence of pertussis among persons aged 10–19 years increased from 5.5 per 100,000 in 2001, to 6.7 per 100,000 in 2002, and 10.9 per 100,000 in 2003.
Hepatitis B
Hepatitis B vaccine is a synthetic, non-infectious vaccine. The incidence of Hepatitis B is 2.1 cases per 100,000 population. The vaccine used to contain thimerosal (mercury) as a preservative and now contains aluminum as an adjuvant.
Based on data from CDC, the incidence of acute hepatitis B in the United States has declined steadily since the late 1980s. Between 1987 and 2004, the incidence of acute hepatitis B was recently reported by the CDC to be 2.1 per 100,000 (6,212 cases reported).
Pneumovax
As few as 2 cases of invasive pneumococcal pneumonia occur annually per 100,000 population. It contains an aluminum adjuvant.
CDC reported dramatic declines in invasive pneumococcal disease among children less than 5 years old. Overall, invasive pneumococcal disease decreased from 100 cases per 100,000 people in 1998 to 9 cases per 100,000 in 2015. Invasive pneumococcal disease caused by the 13 serotypes covered by PCV13 decreased from 91 cases per 100,000 people in 1998 to 2 cases per 100,000 people in 2015.
Hemophilus influenza b (Hib) vaccine
The incidence of Hib infection is as low as 0.08 cases per 100,000 in children younger than 5 years of age.
In the United States, Hib disease is uncommon. In 2015, the incidence of invasive Hib disease was 0.08 cases per 100,000 in children younger than 5 years of age. It occurs primarily in under-immunized children and in infants too young to have completed the primary immunization series.
In 2015, the incidence of non-b H. influenzae invasive disease was 1.3 per 100,000 in children younger than 5 years of age.
Non-typeable H. influenzae, for which there is no vaccine, now causes the majority of invasive H. influenzae disease in all age groups. In 2015, the incidence of invasive non-typeable H. influenzae disease was 7 cases per 100,000 in children younger than 5 years of age and 2 cases per 100,000 in adults 65 years of age and older.
MMR (Measles)
The MMR vaccine contains live (although allegedly attenuated) viruses and therefore contains no mercury. In the US, the incidence of measles is approximately 2 cases per million population.
The incidence of measles has remained below one case per million since 1997, except in 2014, when 667 measles cases were reported, representing a reported incidence of 2.08 cases per million.
MMR (Mumps)
In the US, the incidence of mumps is less than 2 cases per 100,000 population.
In the United States, approximately 3,000 cases of mumps were reported annually in 1983–1985 (= 1.3–1.55 cases per 100,000 population).
MMR (Rubella)
In the US, the incidence of rubella (German measles) is less than 0.5 cases per 100,000 population.
The largest annual number of cases of rubella in the United States was in 1969, when 58 cases were reported per 100,000 population. In 1983, fewer than 1,000 cases per year were reported in the United States (less than 0.5 cases per 100,000 population).
Varicella (Chicken Pox)
The chicken pox vaccine is a live virus vaccine. The incidence of wild-type chicken pox is highly variable and not reportable.
Influenza
Flu viruses have 100 – 200 different strains and therefore influenza has an unpredictable and variable incidence. 80% of what is commonly diagnosed as “vaccine-preventable” influenza is actually “Influenza-Like Illnesses” (ILI) for which there is no vaccine. The commonly over-promoted annual influenza vaccines that come in multiple-dose vials contain the neurotoxic preservative mercury (thimerosal).
Neurotoxic aluminum adjuvants hyper-stimulate immune responses to whatever protein molecules (look up the critically important concept of “Molecular Mimicry”) come to be attached, explaining the large number of vaccine-induced autoimmune (hyperimmune) disorders that are increasingly occurring in fully-vaccinated populations.
Aluminum adjuvants are used in the following vaccines:
DTaP (diphtheria/Tetanus/ Pertussis (whooping cough); Hepatitis A; Hepatitis B; Haemophilus influenza type b; Meningococcus; and Pneumococcal vaccines.
Posted by: Gary G. Kohls MD Kohls | November 27, 2018 at 11:15 AM
Rebecca
Thanks. I certainly don’t think I am a lone voice but the material is here for people to use.
John
Posted by: John Stone | November 27, 2018 at 09:55 AM
I fear you are "a voice crying in the wilderness," for now John Stone. May the paradigm shift soon.
Posted by: Rebecca Lee | November 27, 2018 at 09:19 AM
John .. Dame Sally - UK's leading government adviser on medical matters responded:
"It is, if anything, a rather naive response citing a shallow collection of studies which were published under political pressure decades after the policy was introduced."
With the utmost respect for you and all the fine work you continue to do .. I suspect Sally's response was far from "naïve" .. defined by Webster's as: "unaffectedly simple; credulous". I think Sally's response is classic "sophistry" .. defined by Webster's as: "misleading but clever reasoning'.
The industry protectors have mastered the art of "sophistry" … to the extent that "sophistry" has replaced "science".
Perhaps Sally's response would be better defined as "crafty" than "naïve".
Posted by: bob moffit | November 27, 2018 at 07:23 AM
https://jbhandleyblog.com/home/meta-analysis-madness
Great letter, John. So detailed and well referenced. It will be interesting to see her response. If it wasn't so serious, it would be laughable that she used the Taylor study to prove the safety of vaccines.
JB Handley produced a great blog 'dissing' this meta analysis in April this year because he was so fed up with 'powers that be' using it as 'proof' there is no link.
Posted by: Susan Welch | November 27, 2018 at 06:36 AM
The MHRA have just been caught out by the #Implantfiles movement (see recent Panorama programme), same issues, the regulator is captured by the industry.
Posted by: Geoff Brandt | November 27, 2018 at 06:27 AM
Torches & Pitchforks time I say - Sally !
The biggest crime in all history, ever ? Sally - what do you think ?
The science of vaccination is based on one complete & total lie after the another.
Fully backed by government and fully backed by the various lamestream medias.
There can only be one conclusion drawn.
Posted by: Hans Litten | November 27, 2018 at 06:25 AM
Excellent letter John.Obviously worth her salary to Pharma.
"And the Department of Health, there are 18 officials on six-figure salaries, of whom the highest paid is Dame Sally Davies, chief medical officer, on £205,000 to £210,000."
https://www.telegraph.co.uk/news/2017/03/05/600-health-quango-chiefs-six-figure-salaries-amid-cash-crisis/
Pharma For Prison
MMR RIP
Posted by: Angus Files | November 27, 2018 at 03:30 AM
Excellent response, thank you John.
It's high time that the definition of "safe" is specified as it differs considerably according to the source of information:
"A safe vaccine" may be interpreted as one which does not cause harm - or it may be a term which is arrived at through the process of manipulated statistics.
Posted by: Sandy Lunoe | November 27, 2018 at 03:18 AM
Excellent letter John.
You have put Dame Sally Davies, 'on the spot'. If she continues to ignore both parental concerns about MMR vaccine and the continuing rise in autism, she will eventually find herself being blamed by an outraged public who trusted her "It's a safe vaccination - we know that" statement.
Posted by: Jenny Allan | November 27, 2018 at 01:47 AM